The Adult Chair
A careful primer for the curious but wary. Psychotherapist Michelle Chalfant and Matt walk through his three-legged framework for understanding psychedelics, the medical, the decriminalization, and the spiritual paths, and why preparation and integration matter as much as the experience itself.
LISTEN
Listen on the show website ↗ Watch on YouTube ↗
Episode summary
On The Adult Chair, host Michelle Chalfant, a psychotherapist, brings Matt on for a careful newcomer's primer aimed at listeners who are curious but wary. He opens with a framework he uses for people new to the subject, three legs of a stool. The first is the medical model, with legal ketamine, the Johns Hopkins psilocybin work, and the MDMA trials for PTSD. The second is decriminalization, the view that plants should not be illegal, now reflected in cities and in states like Colorado and Oregon. The third is the spiritual leg, the use of these substances as a sacrament protected under religious freedom, which he notes rarely gets enough attention even though the federal approval path for churches remains slow and burdensome.
Matt shares his starting point, a guided psilocybin session in 2019 that reconnected him with his late mother and reordered how he saw his own life, and which sent him back to school for a master's. Asked why these medicines help people change, he describes the quieting of the brain's inner narrator and a window in which neurons fire in new combinations, using the image of fresh snow over worn ski tracks. He frames this as a way of remembering an innate sense of being loved and connected, what Michelle calls reclaiming the true self, and is careful to call a psychedelic a catalyst rather than a magic pill.
Much of the conversation answers the questions her audience tends to ask. On the fear of getting hooked, Matt explains that most classic psychedelics are not addictive and that some are being studied as tools against addiction, while noting ketamine is the exception that warrants care. He points to the long history of LSD research for alcohol use, including the interest the founder of Alcoholics Anonymous took in it. He is also direct about who these medicines are not for, naming active mania, schizophrenia, a history of psychotic breaks, and acute crisis as reasons to wait, and points to the pharmacist Ben Malcolm for checking medication interactions.
He and Michelle both stress that the change happens in integration, the work of making meaning afterward and finding a community to hold it, rather than in the ceremony itself. Matt walks through source, set, and setting as the basics of safer practice, including resources for testing substances, and answers questions about group size and how to vet a provider. On microdosing he lays out the sub-perceptual range and the Fadiman and Stamets protocols while noting the research is mixed. He closes on the book's modest aim, that even people who never take a psychedelic can understand them well enough to make informed choices or to vote thoughtfully.